Diana Törmä
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Diana Törmä has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anna-Kaisa Ruotsalainen
A.I. Virtanen Institute University of Eastern Finland Kuopio Finland
1 shared publication - Jarkko P. Hytönen
A.I. Virtanen Institute University of Eastern Finland Kuopio Finland
1 shared publication Mimmi Rinta‐Harri
A.I. Virtanen Institute University of Eastern Finland Kuopio Finland
1 shared publicationSeppo Ylä‐Herttuala
A.I. Virtanen Institute University of Eastern Finland Kuopio Finland
1 shared publicationTuisku Suoranta
A.I. Virtanen Institute University of Eastern Finland Kuopio Finland
1 shared publication
Latest Publications
- Open Access
Low and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice
Hypertension is a major contributor to cardiovascular diseases, being the most common comorbidity and the biggest risk factor in heart failure with preserved ejection fraction. Angiotensin II (Ang II) is a known hypertension and heart failure inducer in mice, but its role in the causality in phenotype development remains unclear. Here, hypertension was induced with low (LowA) or high (HighA) pressor doses of Ang II in mice. Both LowA and HighA groups demonstrated equal levels of hypertension with aortic dilatation and decreased aortic wall strain, but only HighA developed left ventricular hypertrophy with advanced cardiac dysfunction, demonstrating the hypertension‐independent effects of Ang II on myocardial remodeling. Alterations in electrical conductivity occurred similarly in both groups, with prominent ECG waveform aberrations. The study demonstrates two distinct hypertensive heart disease phenotypes induced by Ang II, providing a valuable preclinical framework that emphasizes the critical role of Ang II in diastolic dysfunction and vascular remodeling beyond its effects on the regulation of blood pressure.
Open AccessLow and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice
Hypertension is a major contributor to cardiovascular diseases, being the most common comorbidity and the biggest risk factor in heart failure with preserved ejection fraction. Angiotensin II (Ang II) is a known hypertension and heart failure inducer in mice, but its role in the causality in phenotype development remains unclear. Here, hypertension was induced with low (LowA) or high (HighA) pressor doses of Ang II in mice. Both LowA and HighA groups demonstrated equal levels of hypertension with aortic dilatation and decreased aortic wall strain, but only HighA developed left ventricular hypertrophy with advanced cardiac dysfunction, demonstrating the hypertension‐independent effects of Ang II on myocardial remodeling. Alterations in electrical conductivity occurred similarly in both groups, with prominent ECG waveform aberrations. The study demonstrates two distinct hypertensive heart disease phenotypes induced by Ang II, providing a valuable preclinical framework that emphasizes the critical role of Ang II in diastolic dysfunction and vascular remodeling beyond its effects on the regulation of blood pressure.